Evidence map›Paper›PMID 22429904›Full record

ReviewPhysiology & behavior2012

Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y.

Mallory E Bowers, Dennis C Choi, Kerry J Ressler

Abstract readReview
In one paragraph

Review in Physiology & behavior, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 1 synthesis or guideline pooled it, 155 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. A New Insight into the Role of CART Peptide in Serotonergic Function and Anxiety.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  8. Review
  9. Review
  10. Basolateral amygdala neuropeptide Y system modulates binge ethanol consumption.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Neuropathic pain: Mechanisms and therapeutic strategies.Frontiers in cell and developmental biology · 2023
    Review
  17. Review
  18. Therapeutic Implications of microRNAs in Depressive Disorders: A Review.International journal of molecular sciences · 2022
    Review
  19. Review
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mallory E BowersCenter for Behavioral Neuroscience, Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, United States.
Dennis C Choi
Kerry J Ressler
Emory University · US

Funding

YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI ALTMAN, JOHN DAVID · 1985 to 2011
$114.0M
Genetic and Trauma-Related Risk Factors for PTSDR01MH071537 · NIMH · EMORY UNIVERSITY · PI RESSLER, KERRY J. · 2005 to 2014
$8.5M
Genetic and estrogen-dependent regulation of the human PAC1R receptor and PTSDR01MH096764 · NIMH · MCLEAN HOSPITAL · PI RESSLER, KERRY J. · 2012 to 2016
$2.1M
Molecular Regulation of GABA(A) Receptor Function in AmygdalaR01DA019624 · NIDA · EMORY UNIVERSITY · PI RESSLER, KERRY J. · 2006 to 2010
$1.8M
The role of cortical BDNF in the regulation of fear conditioning and extinctionF32MH085443 · NIMH · EMORY UNIVERSITY · PI CHOI, DENNIS CLARENCE · 2009 to 2011
$157k
Endocannabinoid and Cholecystokinin Interactions Mediating Extinction LearningF31MH097397 · NIMH · EMORY UNIVERSITY · PI BOWERS, MALLORY · 2012 to 2014
$75k
Howard Hughes Medical InstituteNCRR NIH HHS P51 RR000165NCRR NIH HHS P51RR000165NIDA NIH HHS R01DA01962NIDA NIH HHS R01 DA019624NIMH NIH HHS F31 MH097397NIMH NIH HHS F32 MH085443NIMH NIH HHS F32MH085443NIMH NIH HHS R01 MH071537NIMH NIH HHS R01 MH096764
6 · The paper itself

Abstract

The neural circuitry of fear likely underlies anxiety and fear-related disorders such as specific and social phobia, panic disorder, and posttraumatic stress disorder. The primary pharmacological treatments currently utilized for these disorders include benzodiazepines, which act on the GABAergic receptor system, and antidepressants, which modulate the monamine systems. However, recent work on the regulation of fear neural circuitry suggests that specific neuropeptide modulation of this system is of critical importance. Recent reviews have examined the roles of the hypothalamic-pituitary-adrenal axis neuropeptides as well as the roles of neurotrophic factors in regulating fear. The present review, instead, will focus on three neuropeptide systems which have received less attention in recent years but which are clearly involved in regulating fear and its extinction. The endogenous opioid system, particularly activating the μ opioid receptors, has been demonstrated to regulate fear expression and extinction, possibly through functioning as an error signal within the ventrolateral periaqueductal gray to mark unreinforced conditioned stimuli. The cholecystokinin (CCK) system initially led to much excitement through its potential role in panic disorder. More recent work in the CCK neuropeptide pathway suggests that it may act in concordance with the endogenous cannabinoid system in the modulation of fear inhibition and extinction. Finally, older as well as very recent data suggests that neuropeptide Y (NPY) may play a very interesting role in counteracting stress effects, enhancing extinction, and enhancing resilience in fear and stress preclinical models. Future work in understanding the mechanisms of neuropeptide functioning, particularly within well-known behavioral circuits, are likely to provide fascinating new clues into the understanding of fear behavior as well as suggesting novel therapeutics for treating disorders of anxiety and fear dysregulation.

Indexed as

AnimalsAnxietyBrainCholecystokininFearHumansNeuropeptide YOpioid PeptidesCholecystokininNeuropeptide YOpioid Peptides

Identifiers

PMID22429904
PMCPMC3532931
OpenAlexW1984917106

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.